NCT07034677

Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Lars Rejnmark · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.

Detailed description

The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme. Patients will do weekly blood sampling and 24 hour urine collection every second week.

Conditions

• Hypoparathyroidism Post-surgical

Interventions

Type	Name	Description
DRUG	Indapamide 1.5 MG SR	14 days treatment with indapamide 1.5 mg/day compared to placebo
DRUG	Placebo	14 days treatment with placebo

Timeline

• Start date: 2025-08-01
• Primary completion: 2025-12-01
• Completion: 2025-12-01
• First posted: 2025-06-24
• Last updated: 2025-08-11

Locations

1 site across 1 country: Denmark